サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1504923

人工多能性幹細胞（iPSC）市場、シェア、規模、動向、産業分析レポート：派生細胞別、ワークフロー別、用途別、地域別、セグメント別予測、2024年～2032年

Induced Pluripotent Stem Cell Market Share, Size, Trends, Industry Analysis Report, By Derived Cell; By Workflow; By Application; By Region; Segment Forecast, 2024 - 2032

出版日
ページ情報
英文 118 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.95円
人工多能性幹細胞（iPSC）市場、シェア、規模、動向、産業分析レポート：派生細胞別、ワークフロー別、用途別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年05月01日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、人工多能性幹細胞（iPSC）の世界市場規模は2032年までに43億5,556万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

高齢者人口の増加、慢性疾患の増加、研究開発の進歩がiPSC市場の成長拡大に寄与しています。この成長は、先進的な医薬品開発と試験に関心を持つ世界中の製薬会社から多額の投資を引き寄せており、それによってiPSC市場全体の成長に貢献しています。

幹細胞のワークフロー全体は複雑ではあるが、新規参入者にとってiPSC製造のまたとない機会となっています。iPSCの生産に関わる重要かつ複雑なプロセスには、作製、初期化、様々な目的の細胞タイプへの分化などがあり、これらには専門知識とリソースの両方が必要となります。しかし、市販のiPSC由来細胞の購入やプログラミングのアウトソーシングという選択肢があるため、新規参入者はこの分野を開拓し、その成長に貢献することが奨励されています。

市場参入の選択肢がいくつかある中で、リプログラミングや自社での分化に集中的に取り組む、市販の製品ポートフォリオからiPSC由来の細胞タイプを購入する、あるいは第三者の提供者と契約を結んでカスタマイズされたモデルを作製するなど、いくつかの動向が観察されます。この動向は、多くの疾患モデル、表現型アッセイ、毒物学的検査にiPSCをベースとしたモデルを用いる可能性に拍車をかけています。

バイオ医薬品は、ホルモン、ワクチン、モノクローナル抗体、治療用酵素、血液因子など、微生物由来の医薬品です。これらの医薬品は特異性が高く、個別化医療などヘルスケアに新たな道を開いています。このアプローチでは、患者の生理学的、生物学的、遺伝的構成に応じて、特定の生体分子を用いて様々な疾患や症状を治療します。従来の医薬品は適用範囲が限られており、バイオテクノロジー業界にはプレーヤーが少ないため、細胞培養技術の成長に拍車がかかっています。

iPSC市場レポートハイライト

2023年、世界市場は、心筋細胞が支配的なセグメントとして台頭し、著しい成長を遂げました。これは、心臓の収縮とポンプ作用を担う心臓の特殊な筋肉細胞である心筋細胞が、治療応用の可能性から大きな注目を集めているためです。

再生医療産業は、今後数年間で大幅な成長率を遂げると予測されています。再生医療には、傷害や疾病に苦しむ個人の正常な機能を回復させるために、組織や臓器の修復、置換、再生を目標とする治療技術が含まれます。

北米地域は、生物医学分野における広範な研究と技術革新により、世界市場を独占しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の人工多能性幹細胞（iPSC）市場の洞察

  • ワークフロースナップショット
  • 人工多能性幹細胞（iPSC）市場力学
    • 促進要因と機会
      • 身体再建手術と組織工学の需要増加
      • ワクチン製造、人工臓器、培地、バイオ医薬品の需要増加
    • 抑制要因と課題
      • 動物に関する倫理的懸念
  • PESTEL分析
  • 人工多能性幹細胞（iPSC）市場のワークフロー動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の人工多能性幹細胞（iPSC）市場：派生細胞別

  • 主な調査結果
  • イントロダクション
  • 肝細胞
  • 線維芽細胞
  • 神経細胞
  • 羊膜細胞
  • 心筋細胞
  • その他

第6章 世界の人工多能性幹細胞（iPSC）市場：用途別

  • 主な調査結果
  • イントロダクション
  • 製造業
  • 学術研究
  • 医薬品開発と発見
  • 毒性スクリーニング
  • 再生医療

第7章 世界の人工多能性幹細胞（iPSC）市場：ワークフロー別

  • 主な調査結果
  • イントロダクション
  • リプログラミング
  • 細胞培養
  • 細胞特性評価/分析
  • エンジニアリング
  • その他

第8章 世界の人工多能性幹細胞（iPSC）市場：地域

  • 主な調査結果
  • イントロダクション
    • 人工多能性幹細胞（iPSC）市場評価：地域、2019年～2032年
  • 北米
    • 北米：派生細胞別、2019-2032年
    • 北米：ワークフロー別、2019年～2032年
    • 北米：用途別、2019-2032年
    • 米国
    • カナダ
  • 欧州
    • 欧州：派生セル別、2019-2032年
    • 欧州：ワークフロー別、2019-2032年
    • 欧州：用途別、2019-2032年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
  • アジア太平洋地域
    • アジア太平洋地域：派生セル別、2019-2032年
    • アジア太平洋地域：ワークフロー別、2019-2032年
    • アジア太平洋地域：用途別、2019-2032年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 中東・アフリカ：派生セル別、2019-2032年
    • 中東・アフリカ：ワークフロー別、2019-2032年
    • 中東・アフリカ：用途別、2019-2032年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：派生セル別、2019年～2032年
    • ラテンアメリカ：ワークフロー別、2019-2032年
    • ラテンアメリカ：用途別、2019-2032年
    • メキシコ
    • ブラジル
    • アルゼンチン

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Astellas Pharma Inc
  • Axol Bioscience Ltd
  • Cynata Therapeutics Limited
  • Fate Therapeutics
  • FUJIFILM Holdings Corporation（Cellular Dynamics）
  • Ncardia
  • REPROCELL Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • ViaCyte, Inc
図表

List of Tables

  • Table 1 Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 2 Global Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 3 Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 4 Induced Pluripotent Stem Cell (iPSC) Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 6 North America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 7 North America: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 8 U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 9 U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 10 U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 11 Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 12 Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 13 Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 14 Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 15 Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 16 Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 17 UK: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 18 UK: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 19 UK: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 20 France: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 21 France: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 22 France: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 23 Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 24 Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 25 Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 26 Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 27 Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 28 Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 29 Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 30 Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 31 Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 32 Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 33 Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 34 Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 35 Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 36 Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 37 Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 41 China: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 42 China: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 43 China: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 44 India: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 45 India: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 46 India: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 47 Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 48 Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 49 Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 50 Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 51 Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 52 Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 53 Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 54 Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 55 Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 56 South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 57 South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 58 South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 65 UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 66 UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 67 UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 68 Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 69 Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 70 Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 71 South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 72 South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 73 South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 74 Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 75 Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 76 Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 77 Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 78 Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 79 Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 80 Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 81 Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 82 Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 83 Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 84 Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 85 Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Induced Pluripotent Stem Cell (iPSC) Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8. Market by Derived Cell
  • Figure 9. Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2022 & 2032 (USD Million)
  • Figure 10. Market by Workflow
  • Figure 11. Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2022 & 2032 (USD Million)
  • Figure 12. Induced Pluripotent Stem Cell (iPSC) Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Induced Pluripotent Stem Cell (iPSC) Market
目次
Product Code: PM2014

The global Induced Pluripotent Stem Cell (iPSC) market size is expected to reach USD 4,355.56 Million by 2032, according to a new study by Polaris Market Research. The report "iPSC Market Share, Size, Trends, Industry Analysis Report, By Derived Cell (Hepatocytes, Fibroblasts, Neural Cells, Amniotic Cells, Cardiomyocytes, Others); By Workflow; By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing elderly population, rising cases of chronic diseases, and advancements in research and development are contributing to the increasing growth of the iPSC market. This growth is attracting significant investments from pharmaceutical companies worldwide, who are interested in advanced drug development and testing, and is thereby catering to the overall growth of the iPSC market.

The overall stem cell workflow, although complex, presents a unique opportunity for new entrants in the production of iPSC. Some of the critical and complex processes involved in the production of iPSC include generation, reprogramming, and differentiation into various desired cell types, which require both expertise and resources. However, with the option of commercial iPSC-derived cell purchase or outsourcing programming, new entrants are encouraged to explore this field and contribute to its growth.

With several market entry options available, several trends are observed, such as concentrated efforts on reprogramming and in-house differentiation, purchase of iPSC-derived cell types from off-the-shelf product portfolios, or entering into agreements with third-party purveyors to produce customized models. This trend has spurred a range of possibilities that will feature iPSC-based models for a host of disease models, phenotypic assays, and toxicology testing.

Biopharmaceuticals are drugs that are derived from microbiological sources such as hormones, vaccines, monoclonal antibodies, therapeutic enzymes, blood factors, and so on. These drugs are highly specific and have opened up new avenues in healthcare, such as personalized medicine. This approach involves treating various diseases or conditions using specific biomolecules depending on the patient's physiological, biological, and genetic makeup. As conventional pharmaceuticals have limited applicability and there are few players in the biotechnology industry, the growth of cell culture technology has been fueled.

iPSC Market Report Highlights

In 2023, the global market witnessed significant growth, with cardiomyocytes emerging as the dominant segment. This is because cardiomyocytes, specialized muscle cells in the heart responsible for its contraction and pumping action, have gained significant attention due to their potential for therapeutic applications.

The regenerative medicine industry is projected to experience a substantial growth rate in the upcoming years. Regenerative medicine involves therapeutic techniques that target the repair, replacement, or regeneration of tissues or organs in order to restore normal function in individuals who are suffering from injury or disease.

The North American region dominated the global market, owing to its extensive research and innovation in the field of biomedical science.

The global key market players include Astellas Pharma Inc., Axol Bioscience Ltd., Cynata Therapeutics Limited, Fate Therapeutics, FUJIFILM Holdings Corporation (Cellular Dynamics), Ncardia, REPROCELL Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., ViaCyte, Inc, etc.

Polaris Market Research has segmented the iPSC market report based on derived cell, workflow, application, and region:

iPSC, Derived Cell Outlook (Revenue - USD Million, 2019 - 2032)

  • Hepatocytes
  • Fibroblasts
  • Neural Cells
  • Excitatory Neurons
  • Inhibitory Neurons
  • Amniotic Cells
  • Cardiomyocytes
  • Others

iPSC, Workflow Outlook (Revenue - USD Million, 2019 - 2032)

  • Reprogramming
  • Cell Culture
  • Cell Characterization / Analysis
  • Engineering
  • Others

iPSC, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Manufacturing
  • Academic Research
  • Drug Development & Discovery
  • Toxicity Screening
  • Regenerative Medicine

iPSC, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Austria
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Induced Pluripotent Stem Cell (iPSC) Market Insights

  • 4.1. Induced Pluripotent Stem Cell (iPSC) Market - Workflow Snapshot
  • 4.2. Induced Pluripotent Stem Cell (iPSC) Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing demand for body reconstruction procedures and tissue engineering
      • 4.2.1.2. Rising Demand for Vaccine Production, Artificial Organs, Media, and Biopharmaceuticals
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1 Ethical Concerns Pertaining to Animals
    • 4.2.3 Porter's Five Forces Analysis
      • 4.2.3.1. Bargaining Power of Suppliers (Moderate)
      • 4.2.3.2. Threats of New Entrants: (Low)
      • 4.2.3.3. Bargaining Power of Buyers (Moderate)
      • 4.2.3.4. Threat of Substitute (Moderate)
      • 4.2.3.5 Rivalry among existing firms (High)
  • 4.3. PESTEL Analysis
  • 4.4. Induced Pluripotent Stem Cell (iPSC) Market Workflow Trends
  • 4.5. Value Chain Analysis
  • 4.6. COVID-19 Impact Analysis

5. Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • 5.3. Hepatocytes
    • 5.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Hepatocytes, by Region, 2019-2032 (USD Million)
  • 5.4. Fibroblasts
    • 5.4.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Fibroblasts, by Region, 2019-2032 (USD Million)
  • 5.5. Neural Cells
    • 5.5.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Neural Cells, by Region, 2019-2032 (USD Million)
    • 5.5.2. Excitatory Neurons
      • 5.5.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Excitatory Neurons, by Region, 2019-2032 (USD Million)
    • 5.5.3. Inhibitory Neurons
      • 5.5.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Inhibitory Neurons, by Region, 2019-2032 (USD Million)
  • 5.6. Amniotic Cells
    • 5.6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Amniotic Cells, by Region, 2019-2032 (USD Million)
  • 5.7. Cardiomyocytes
    • 5.7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Cardiomyocytes, by Region, 2019-2032 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Induced Pluripotent Stem Cell (iPSC) Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • 6.3. Manufacturing
    • 6.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Manufacturing, by Region, 2019-2032 (USD Million)
  • 6.4. Academic Research
    • 6.4.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Academic Research, by Region, 2019-2032 (USD Million)
  • 6.5. Drug Development & Discovery
    • 6.5.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Drug Development & Discovery, by Region, 2019-2032 (USD Million)
  • 6.6. Toxicity Screening
    • 6.6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Toxicity Screening, by Region, 2019-2032 (USD Million)
  • 6.7. Regenerative Medicine
    • 6.7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Regenerative Medicine, by Region, 2019-2032 (USD Million)

7. Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • 7.3. Reprogramming
    • 7.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Reprogramming, By Region, 2019-2032 (USD Million)
  • 7.4. Cell Culture
    • 7.4.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Cell Culture, By Region, 2019-2032 (USD Million)
  • 7.5. Cell Characterization / Analysis
    • 7.5.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Cell Characterization / Analysis, By Region, 2019-2032 (USD Million)
  • 7.6. Engineering
    • 7.6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Engineering, By Region, 2019-2032 (USD Million)
  • 7.7. Others
    • 7.7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Induced Pluripotent Stem Cell (iPSC) Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Induced Pluripotent Stem Cell (iPSC) Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Induced Pluripotent Stem Cell (iPSC) Market - North America
    • 8.3.1. North America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
    • 8.3.2. North America: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
    • 8.3.3. North America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.3.4. Induced Pluripotent Stem Cell (iPSC) Market - U.S.
      • 8.3.4.1. U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.3.5. Induced Pluripotent Stem Cell (iPSC) Market - Canada
      • 8.3.5.1. Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • 8.4. Induced Pluripotent Stem Cell (iPSC) Market - Europe
    • 8.4.1. Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
    • 8.4.3. Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.4.4. Induced Pluripotent Stem Cell (iPSC) Market - UK
      • 8.4.4.1. UK: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.4.5. Induced Pluripotent Stem Cell (iPSC) Market - France
      • 8.4.5.1. France: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.4.5.3. France: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.4.6. Induced Pluripotent Stem Cell (iPSC) Market - Germany
      • 8.4.6.1. Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.4.7. Induced Pluripotent Stem Cell (iPSC) Market - Italy
      • 8.4.7.1. Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.4.8. Induced Pluripotent Stem Cell (iPSC) Market - Spain
      • 8.4.8.1. Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.4.9. Induced Pluripotent Stem Cell (iPSC) Market - Netherlands
      • 8.4.9.1. Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.4.10. Induced Pluripotent Stem Cell (iPSC) Market - Russia
      • 8.4.10.1. Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • 8.5. Induced Pluripotent Stem Cell (iPSC) Market - Asia Pacific
    • 8.5.1. Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.5.4. Induced Pluripotent Stem Cell (iPSC) Market - China
      • 8.5.4.1. China: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.5.4.3. China: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.5.5. Induced Pluripotent Stem Cell (iPSC) Market - India
      • 8.5.5.1. India: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.5.5.3. India: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.5.6. Induced Pluripotent Stem Cell (iPSC) Market - Malaysia
      • 8.5.6.1. Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.5.7. Induced Pluripotent Stem Cell (iPSC) Market - Japan
      • 8.5.7.1. Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.5.8. Induced Pluripotent Stem Cell (iPSC) Market - Indonesia
      • 8.5.8.1. Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.5.9. Induced Pluripotent Stem Cell (iPSC) Market - South Korea
      • 8.5.9.1. South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • 8.6. Induced Pluripotent Stem Cell (iPSC) Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.6.4. Induced Pluripotent Stem Cell (iPSC) Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.6.5. Induced Pluripotent Stem Cell (iPSC) Market - UAE
      • 8.6.5.1. UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.6.6. Induced Pluripotent Stem Cell (iPSC) Market - Israel
      • 8.6.6.1. Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.6.7. Induced Pluripotent Stem Cell (iPSC) Market - South Africa
      • 8.6.7.1. South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • 8.7. Induced Pluripotent Stem Cell (iPSC) Market - Latin America
    • 8.7.1. Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.7.4. Induced Pluripotent Stem Cell (iPSC) Market - Mexico
      • 8.7.4.1. Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.7.5. Induced Pluripotent Stem Cell (iPSC) Market - Brazil
      • 8.7.5.1. Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.7.6. Induced Pluripotent Stem Cell (iPSC) Market - Argentina
      • 8.7.6.1. Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Astellas Pharma Inc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Axol Bioscience Ltd
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Cynata Therapeutics Limited
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Fate Therapeutics
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. FUJIFILM Holdings Corporation (Cellular Dynamics)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Ncardia
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. REPROCELL Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Takara Bio Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Thermo Fisher Scientific Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. ViaCyte, Inc
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development